Xoma shifts manufacturing to contractor, cuts 84 jobs

Xoma Corp. will cut 84 jobs — about one-third of its workforce — as the Berkeley-based drug developer shifts much of its manufacturing to a contractor.
Xoma (NASDAQ: XOMA), which officially took “interim” off CEO John Varian’s title, said Thursday that it will eliminate 50 jobs immediately and cut the other 34 jobs by the end of the first quarter.